Spartan Delta Corp. (TSE:SDE – Get Free Report) has received an average rating of “Buy” from the ten ratings firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, seven have issued a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is C$5.50.
A number of equities research analysts have issued reports on the stock. National Bankshares cut their price objective on shares of Spartan Delta from C$6.00 to C$5.50 in a report on Friday, September 27th. BMO Capital Markets cut their target price on shares of Spartan Delta from C$6.00 to C$5.00 in a research note on Friday. Finally, Cormark upgraded shares of Spartan Delta to a “strong-buy” rating in a report on Monday, September 23rd.
View Our Latest Analysis on Spartan Delta
Spartan Delta Trading Down 2.2 %
Spartan Delta (TSE:SDE – Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported C$0.02 earnings per share for the quarter. The firm had revenue of C$60.55 million during the quarter. Spartan Delta had a return on equity of 37.82% and a net margin of 50.10%. On average, sell-side analysts anticipate that Spartan Delta will post 0.305004 earnings per share for the current fiscal year.
Spartan Delta Company Profile
Spartan Delta Corp. engages in the exploration, development, and production of oil and natural gas reserves in the Western Canada. Its assets are located in Montney and Deep Basin. The company was formerly known as Return Energy Inc and changed its name to Spartan Delta Corp. in May 2020. The company was incorporated in 2006 and is headquartered in Calgary, Canada.
Recommended Stories
- Five stocks we like better than Spartan Delta
- Why Invest in High-Yield Dividend Stocks?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- ETF Screener: Uses and Step-by-Step Guide
- Texas Instruments: The Old-School Tech Titan Still Delivering
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Spartan Delta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spartan Delta and related companies with MarketBeat.com's FREE daily email newsletter.